Osaic Holdings’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $482K | Sell |
3,858
-433
| -10% | -$54.1K | ﹤0.01% | 2856 |
|
|
2025
Q1 | $475K | Buy |
4,291
+541
| +14% | +$59.9K | ﹤0.01% | 2924 |
|
|
2024
Q4 | $512K | Sell |
3,750
-2,298
| -38% | -$314K | ﹤0.01% | 2776 |
|
|
2024
Q3 | $697K | Buy |
6,048
+173
| +3% | +$19.9K | ﹤0.01% | 2569 |
|
|
2024
Q2 | $809K | Sell |
5,875
-7,975
| -58% | -$1.1M | ﹤0.01% | 2366 |
|
|
2024
Q1 | $1.91M | Buy |
13,850
+4,198
| +43% | +$579K | ﹤0.01% | 1730 |
|
|
2023
Q4 | $1.27M | Buy |
9,652
+141
| +1% | +$18.6K | ﹤0.01% | 2273 |
|
|
2023
Q3 | $1.07M | Buy |
9,511
+2,070
| +28% | +$233K | ﹤0.01% | 2579 |
|
|
2023
Q2 | $702K | Sell |
7,441
-5,419
| -42% | -$511K | ﹤0.01% | 2845 |
|
|
2023
Q1 | $1.3M | Sell |
12,860
-763
| -6% | -$77.3K | ﹤0.01% | 2211 |
|
|
2022
Q4 | $1.63M | Sell |
13,623
-231
| -2% | -$27.6K | ﹤0.01% | 1925 |
|
|
2022
Q3 | $1.47M | Buy |
13,854
+3,529
| +34% | +$375K | ﹤0.01% | 1875 |
|
|
2022
Q2 | $1.01M | Buy |
10,325
+279
| +3% | +$27.2K | ﹤0.01% | 2259 |
|
|
2022
Q1 | $1.06M | Buy |
10,046
+858
| +9% | +$90.3K | ﹤0.01% | 2520 |
|
|
2021
Q4 | $784K | Sell |
9,188
-1,112
| -11% | -$94.9K | ﹤0.01% | 2623 |
|
|
2021
Q3 | $990K | Buy |
10,300
+953
| +10% | +$91.6K | ﹤0.01% | 2356 |
|
|
2021
Q2 | $910K | Buy |
9,347
+477
| +5% | +$46.4K | ﹤0.01% | 2450 |
|
|
2021
Q1 | $863K | Buy |
8,870
+987
| +13% | +$96K | ﹤0.01% | 2368 |
|
|
2020
Q4 | $755K | Sell |
7,883
-426
| -5% | -$40.8K | ﹤0.01% | 2280 |
|
|
2020
Q3 | $807K | Buy |
8,309
+3,850
| +86% | +$374K | ﹤0.01% | 2009 |
|
|
2020
Q2 | $531K | Sell |
4,459
-2,404
| -35% | -$286K | ﹤0.01% | 2298 |
|
|
2020
Q1 | $243K | Buy |
+6,863
| New | +$243K | ﹤0.01% | 2714 |
|